Back to User profile » Dr Bobby Saenz
Papers published by Dr Bobby Saenz:
Effect of Cyclosporine Ophthalmic Solution 0.09% on Signs and Symptoms of Dry Eye Disease in Patients Inadequately Controlled on Cyclosporine Ophthalmic Emulsion 0.05%: Results from a Single-Arm, Open-Label, Phase 4 Study
Johnston J, Adler R, Hessen M, Nichols KK, White D, Saenz B, Bowden F III, Periman LM, Truett K, Urbieta M, Mitchell B
Clinical Ophthalmology 2026, 20:583071
Published Date: 4 March 2026
Improved Signs and Symptoms of Dry Eye Disease for Restasis® Patients Following a Single Tearcare® Treatment: Phase 2 of the SAHARA Study
Ayres BD, Bloomenstein MR, Loh J, Chester T, Saenz B, Echegoyen J, Kannarr SR, Rodriguez TC, Dickerson JE Jr
Clinical Ophthalmology 2024, 18:1525-1534
Published Date: 28 May 2024
A Randomized, Controlled Trial Comparing Tearcare® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA) [Response To Letter]
Ayres BD, Bloomenstein MR, Loh J, Chester T, Saenz B, Ehegoyen J, Kannarr SR, Perez VL, Rodriguez TC, Dickerson JE Jr
Clinical Ophthalmology 2024, 18:885-886
Published Date: 20 March 2024
A Randomized, Controlled Trial Comparing Tearcare® and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA)
Ayres BD, Bloomenstein MR, Loh J, Chester T, Saenz B, Echegoyen J, Kannarr SR, Perez VL, Rodriguez TC, Dickerson Jr JE
Clinical Ophthalmology 2023, 17:3925-3940
Published Date: 18 December 2023
Evaluation of Same-Day versus Next-Day Implantation of Intracanalicular Dexamethasone for the Control of Postoperative Inflammation and Pain Following Cataract Surgery
Saenz B, Ferguson TJ, Abraham N, Mueller BH, Parkhurst GD
Clinical Ophthalmology 2021, 15:4615-4620
Published Date: 7 December 2021